Management of First Episode Psychosis
Join Genomind and guest speaker, Dr. Craig Chepke, as they discuss the management of first episode psychosis.
Preventing Medication-Related Falls in Older Adults
Discover which medications increase fall risk and how medication management can help reduce the risk of falls in older adults.
Pharmacokinetics & the Aging Process: Key Considerations for Medication Management
Learn more about age-related changes in pharmacokinetics and how the aging process influences medication management in elderly populations.
Beers Criteria Updates with a Focus on Psychiatric Medications
Learn more about Beers criteria updates and noteworthy changes to potentially inappropriate medications.
Understanding Medicare Coverage of Pharmacogenomic Testing
Learn more about the existing and proposed local Medicare coverage determinations for pharmacogenomic testing.
Psychiatric Case Roundtable
Join Genomind and our panel of experts for a psychiatric case roundtable with a focus on pharmacogenetics.
CYP450 & UGT Gene Spotlight
Learn more about the functions of the CYP450 and UGT enzymes and how variants in these genes can impact drug metabolism.
Pharmacogenetic Considerations for Treatment of the Geriatric Population
Join Genomind for a presentation on Pharmacogenetic Considerations for Treatment of the Geriatric Population.
Depression in the Older Adult Population: Key Considerations for Treatment
See how depression presents in the elderly & why it’s necessary to consider specific characteristics when selecting an antidepressant for elderly patients.
Management of MDD with a Focus on PGx | Part 3: The “Other Antidepressants”
Learn how less commonly prescribed antidepressants may impact treatment decisions for major depressive disorder.
Management of MDD with a Focus on PGx | Part 2: Pharmacokinetic Considerations of First-Line Antidepressants
Learn how pharmacokinetic gene variations may impact first-line pharmacologic treatments for major depressive disorder
Management of MDD with a Focus on PGx | Part 1: Pharmacodynamic Considerations of First-Line Antidepressants
Learn how pharmacodynamic gene variations may impact first-line pharmacologic treatments for major depressive disorder.
Medicare Provides Coverage of the Genomind PGx Test
Major Advancement in Support for Mental Health Patients as Medicare Provides Coverage of the Genomind Professional PGx Express Test and the VA Extends FSS Contract to Help Soldiers and Veterans.
Updates on Treatment of Bipolar Disorders and the Excess of Childhood Onsets in the US
Join Genomind and Dr. Robert Post for a presentation on updates on the treatment of bipolar disorder.
Introducing GenMedPro, Genomind’s Precision Medicine Software
Learn about GenMed✓ Pro – Precision Gene-Drug Interaction Software!
Pharmacokinetic Genes in Generalized Anxiety Disorder Treatment | Part 2: UGT2B15
Learn how mutations in these genes can affect the efficacy and safety of pharmacologic treatments for generalized anxiety disorder.
Pharmacokinetic Genes in Generalized Anxiety Disorder Treatment | Part 1: CYP450
Learn how mutations in these genes can affect the efficacy and safety of pharmacologic treatments for generalized anxiety disorder.
The Role of Pharmacodynamic Genes in Generalized Anxiety Disorder Treatment
Learn how mutations in these genes may impact pharmacologic treatments for generalized anxiety disorder.
What’s New in OCD?
Join Genomind and Dr. Eric Hollander for a presentation on OCD
Management of Generalized Anxiety Disorder with a Focus on Pharmacogenetics
Join Genomind’s Medical Science Liaisons as they present on Management of Generalized Anxiety Disorder with a Focus on Pharmacogenetics.
Clinical Pathological Conference
Join Genomind for a Grand Rounds Clinical Pathological Conference (CPC) Presentation
Monoamine Neurotransmitters and Psychopharmacology
Most psychotropic agents target monoamine neurotransmitters. Learn how these transmitters function and why they are important to psychopharmacology.
MTHFR Gene Spotlight
Learn more about the MTHFR enzyme.
Psychotropic Drug Targeting: Receptors
Learn how drugs modify the actions of G-protein-coupled receptors (GPCRs) and why mutations in these genes may affect drug response, side effect rate, or drug exposure.
Pharmacodynamic (PD) Genes Introduction
Pharmacodynamic genes are genes that can affect therapeutic response or adverse effects to medications. Learn how PD gene variation affects drug response.
Management of Treatment-Resistant Depression with a Focus on Pharmacogenetics
Join Genomind’s Medical Science Liaisons as they present on Management of Treatment-Resistant Depression with a Focus on Pharmacogenetics.
Sleep, Rhythms, and Genetics in Psychiatry
Genomind and guest speaker, Dr. Ruth Benca, MD, PhD, present Sleep, Rhythms, and Genetics in Psychiatry.
Introduction to the Genomind Mental Health Map
Learn about the Genomind Mental Health Map, and the 7 core genetic mental health capabilities.
CPIC: New Findings and Current Guidelines
Genomind and guest speaker, Dr. Kelly E. Caudle, PharmD, PhD, BCPS, discuss CPIC guidelines.
Mental Health 360 – Genomind’s Genetic Test Offerings
Learn about Genomind’s two genetic tests, the Professional PGx Express™ and the Mental Health Map™, and how they embody the Mental Health 360™.
